Literature DB >> 12083850

Laminin isoforms in tumor invasion, angiogenesis and metastasis.

Manuel Patarroyo1, Karl Tryggvason, Ismo Virtanen.   

Abstract

Laminins are a growing family of alphabetagamma heterotrimeric proteins, commonly found in basement membranes (BMs). These large molecules promote cell adhesion and migration via integrins and other cell-surface receptors. Over 12 laminin isoforms are presently known. The various isoforms have a cell- and tissue-specific expression and are differentially recognized by integrins. Expression of laminin isoforms in tumors usually reflects expression in their normal counterparts. However, during tumor invasion, loss of the BM barrier occurs and a discontinuous pattern of laminin staining is observed. In carcinomas, tumor cells at the invading front strongly express intracellularly the gamma2 chain, a component of laminin-5. Remodeling of the vascular BM is observed during angiogenesis, and penetration of several BMs occurs during tumor dissemination and metastasis. Thus, disregulated cell-laminin interactions are major traits of malignant disorders. (c) 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083850     DOI: 10.1016/S1044-579X(02)00023-8

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  115 in total

1.  Alpha6-integrin is expressed on germinal centre B cells and modifies growth of a B-cell line.

Authors:  Helen E Ambrose; Simon D Wagner
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

2.  The role of a recombinant fragment of laminin-332 in integrin alpha3beta1-dependent cell binding, spreading and migration.

Authors:  Hironobu Yamashita; Manisha Tripathi; Mark P Harris; Shanshan Liu; Brandy Weidow; Roy Zent; Vito Quaranta
Journal:  Biomaterials       Date:  2010-03-27       Impact factor: 12.479

3.  Novel human-derived extracellular matrix induces in vitro and in vivo vascularization and inhibits fibrosis.

Authors:  Marc C Moore; Vittoria Pandolfi; Peter S McFetridge
Journal:  Biomaterials       Date:  2015-02-11       Impact factor: 12.479

4.  Focal adhesion kinase is activated in invading fibrosarcoma cells and regulates metastasis.

Authors:  Masuo Hanada; Kazuhiro Tanaka; Yoshihiro Matsumoto; Fumihiko Nakatani; Riku Sakimura; Tomoya Matsunobu; Xu Li; Takamitsu Okada; Tomoyuki Nakamura; Minoru Takasaki; Yukihide Iwamoto
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.

Authors:  Elisabeth L Bair; Man Ling Chen; Kathy McDaniel; Kiyotoshi Sekiguchi; Anne E Cress; Raymond B Nagle; George Timothy Bowden
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 6.  Laminin isoforms in development and disease.

Authors:  Susanne Schéele; Alexander Nyström; Madeleine Durbeej; Jan F Talts; Marja Ekblom; Peter Ekblom
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

Review 7.  Bridging structure with function: structural, regulatory, and developmental role of laminins.

Authors:  Julia Tzu; M Peter Marinkovich
Journal:  Int J Biochem Cell Biol       Date:  2007-08-06       Impact factor: 5.085

8.  The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.

Authors:  Elisabetta Kuhn; Robert J Kurman; Robert A Soslow; Guangming Han; Ann Smith Sehdev; Patrick J Morin; Tian-Li Wang; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

9.  Endothelial cell-laminin interaction: modulation of LDH expression involves alpha6beta4 integrin-FAK-p38MAPK pathway.

Authors:  P R Sudhakaran; R I Viji; M S Kiran; V B Sameer Kumar
Journal:  Glycoconj J       Date:  2008-09-24       Impact factor: 2.916

Review 10.  Laminin-5 in epithelial tumour invasion.

Authors:  Masahiko Katayama; Kiyotoshi Sekiguchi
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.